Author

Jean‐François Rolland

Observed names: J. F. Rolland, J. Rolland, J.-F. Rolland, J.F. Rolland, J.‐F. Rolland, Jean F. Rolland, Jean Francois Rolland, Jean-Francois Rolland, Jean-François Rolland, Jean-François Rolland, Jean-francois Rolland, JeanFrancois Rolland, Jean‐Francois Rolland, J‐F Rolland

Institution: Axxam (Italy)

Observed institutions: Xention (United Kingdom), Axxam (Italy), Istituto Tumori Bari, Max Planck Institute for Biophysical Chemistry, University of Bari Aldo Moro, UCLouvain, KU Leuven

ORCID: 0000-0002-7420-8272

Observed ORCID: 0000-0002-7420-8272

OpenAlex ID: A5017859893

A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice

2005 · Annamaria De Luca, Beatrice Nico, et al. · American Journal Of Pathology · 130

PDF

Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches

2020 · Maria Cristina D’Adamo, Antonella Liantonio, et al. · International Journal of Molecular Sciences · 112

PDF

SERCA3 Ablation Does Not Impair Insulin Secretion but Suggests Distinct Roles of Different Sarcoendoplasmic Reticulum Ca2+ Pumps for Ca2+ Homeostasis in Pancreatic β-cells

2002 · Abdelilah Arredouani, Yves Guiot, et al. · Diabetes · 103

Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests

2009 · Rosa Burdi, Jean-François Rolland, et al. · Journal of Applied Physiology · 83

Role of tumour necrosis factor α, but not of cyclo‐oxygenase‐2‐derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach

2007 · S. Pierno, B. Nico, et al. · Neuropathology and Applied Neurobiology · 65

2005 · Bodvael Fraysse, Jean-François Desaphy, et al. · Neurobiology of Disease · 64

Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity

2012 · Letizia Porcelli, Anna E. Quatrale, et al. · Molecular Oncology · 63

PDF

A long-term treatment with taurine prevents cardiac dysfunction in mdx mice

2018 · Antonietta Mele, Paola Mantuano, et al. · Translational research · 58

Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points

2017 · Roberta Francesca Capogrosso, Paola Mantuano, et al. · Journal of Applied Physiology · 57

Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy

2018 · Paola Mantuano, Francesca Sanarica, et al. · Biochemical Pharmacology · 55

Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC‐1 channel regulation and expression

2009 · S Pierno, GM Camerino, et al. · British Journal of Pharmacology · 53

PDF

Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy

2010 · A. Cozzoli, J.-F. Rolland, et al. · Neuropathology and Applied Neurobiology · 50

First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant

2006 · Rosa Burdi, Maria Paola Didonna, et al. · Neuromuscular Disorders · 50

Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle

2008 · Annamaria De Luca, Beatrice Nico, et al. · Neurobiology of Disease · 49

Feedback Control of the ATP-Sensitive K+ Current by Cytosolic Ca2+ Contributes to Oscillations of the Membrane Potential in Pancreatic β-Cells

2002 · Jean-François Rolland, Jean-Claude Henquin, et al. · Diabetes · 49

PDF

Overactivity of exercise-sensitive cation channels and their impaired modulation by IGF-1 in mdx native muscle fibers: Beneficial effect of pentoxifylline

2006 · Jean-François Rolland, Annamaria De Luca, et al. · Neurobiology of Disease · 45

An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function

2013 · Sabata Pierno, Domenico Tricarico, et al. · AGE · 38

G Protein-independent Activation of an Inward Na+Current by Muscarinic Receptors in Mouse Pancreatic β-Cells

2002 · Jean-François Rolland, Jean-Claude Henquin, et al. · Journal of Biological Chemistry · 37

Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds

2017 · Tania Gamberi, Tania Fiaschi, et al. · Journal of Proteomics · 33

PDF

Inhibition of Protein Synthesis Sequentially Impairs Distinct Steps of Stimulus-secretion Coupling in Pancreatic Cells

2001 · Maria-Jose Garcia-Barrado, Magalie A. Ravier, et al. · Endocrinology · 30

PDF

Atypical Ca2+‐induced Ca2+ release from a sarco‐endoplasmic reticulum Ca2+‐ATPase 3‐dependent Ca2+ pool in mouse pancreatic β‐cells

2004 · Melanie C. Beauvois, Abdelilah Arredouani, et al. · The Journal of Physiology · 28

Identification of Selective Inhibitors of the Potassium Channel Kv1.1–1.2(3) by High‐Throughput Virtual Screening and Automated Patch Clamp

2012 · Sören J. Wacker, Wiktor Jurkowski, et al. · ChemMedChem · 23

PDF

A potassium channel agonist protects hearing function and promotes outer hair cell survival in a mouse model for age-related hearing loss

2022 · Barbara Peixoto Pinheiro, Marcus Müller, et al. · Cell Death and Disease · 22

PDF

Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies

2019 · F. Sanarica, P. Mantuano, et al. · Pharmacological Research · 19

Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential

2018 · Michela De Bellis, Francesca Sanarica, et al. · Frontiers in Pharmacology · 18

PDF

Works count: 64

Citation count: 1,450

H-index: 22

I10-index: 30